CMDBioscience Appoints Bernhardt Trout, Phd To It's Scientific Advisory Board

April 27, 2010 - PRLog -- ORANGE, Conn., March 31, 2010 -- CMDBioscience, a CT based biotechnology company specializing in computer-aided peptide drug discovery, announced today the appointment of Bernhardt Trout, Ph.D. to its scientific advisory board.

Dr Trout’s research focuses on molecular engineering for the stabilization of biotherapeutics, crystallization, and the development of pharmaceutical separation processes. He is currently Director of the Novartis-MIT Center for Continuous Manufacturing and the Co-Chair of the Singapore-MIT Alliance Program on Chemical and Pharmaceutical Engineering.  He has published over 70 papers and currently has 4 patent applications submitted.  

“We are very excited about Dr Trout's appointment to the CMDBioscience Scientific Advisory Board.  Dr Trout's considerable experience in the field of biologics-based drug development complements our existing board members and provides CMDBioscience with outstanding scientific leadership."  said Dr. Joseph Audie, the CEO and cofounder of CMD Bioscience.

CMDBioscience, a privately held company based in Orange, CT, is an innovative leader in the development and application of advanced computational methodologies, expediting time to market for our partner's peptide-based products.  Serving the pharmaceutical and biotech industries through international partnerships, collaborations, technologies and products, CMDBioscience is setting the standard for computational peptide discovery.

To learn more about CMDBioscience, please visit their website: http://www.cmdbioscience.com.
.  
   
CMD Bioscience media contact:
Jennifer Muller
Marketing On Demand
860-604-6668
jmull@themodco.com
www.cmdbioscience.com

# # #

CMDBioscience, a privately held company based in Orange, CT, is an innovative leader in the development and application of advanced computational methodologies, expediting time to market for our partner's peptide-based products. Serving the pharmaceutical and biotech industries through international partnerships, collaborations, technologies and products, CMDBioscience is setting the standard for computational peptide discovery.

To learn more about CMDBioscience, please visit their website: http://www.cmdbioscience.com.